Novartis legt an Fachkongress neue Daten zum Wirkstoff zur Behandlung von Erdnussallergien vor

- Novartis präsentiert an einem Fachkongress in Philadelphia neue Daten zur Sicherheit und Wirksamkeit des Wirkstoffs Remibrutinib.


2 w.
Science
ID: -7318772103746737169


Similar News expand_more


Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Science
Weather
Science
Sport
Science
Politics
Science
Science
Science
Science
Science
Sport
Politics
Sport
Science
Science
Sport
Science
Science
Entertainment
Science
Entertainment
Weather
Entertainment
Politics
Science
Technology
Military
Sport
Science
Politics
Science
Entertainment
Sport
Education
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down